In 2015 the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) informed DFSNZ about the results of Medsafe’s investigation into an internet drug supplier NZ Clenbuterol and provided DFSNZ details about the internet purchase in 2014 of a prohibited substance made by the rugby player Glen Beadle.
Hereafter in October 2018 Drug Free Sport New Zealand (DFSNZ) has reported two anti-doping rule violations against Glen Beadle for the use and possession of the prohibited substance Clenbuterol.
After notification the Athlete gave a prompt admission, waived his right to be heard, accepted a provisional suspension and the sanction proposed by DFSNZ.
The parties in this case reached an agreement and filed a joint memorandum in relation to the sanction for approval into a decision of the New Zealand Rugby Union Judicial Committee.
The Committee considers that the Athlete gave a prompt admission and that there were substantial delays in the proceedings not attributed to the Athlete. Therefore the New Zealand Rugby Union Judicial Committee decides on 27 February 2019 to impose a 2 year period of ineligibility on the Athlete starting backdated on 26 October 2017.